|
|
|
Volumn 10, Issue 6, 2007, Pages 366-369
|
|
American association for cancer research 98th annual meeting. Angiogenesis and anti-angiogenesis in cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 (4 FLUORO 2 METHYL 5 INDOLYLOXY) 6 METHOXY 7 [3 (1 PYRROLIDINYL)PROPOXY]QUINAZOLINE;
ANGIOCEPT;
ANGIOGENESIS INHIBITOR;
ANGIOPOIETIN 2;
BEVACIZUMAB;
BMS 582664;
BRIVANIB ALANINATE;
CEDIRANIB;
CT 322;
CVX 37;
ENDOSTAR;
ENDOSTATIN;
EPHRIN RECEPTOR B2;
EPHRIN RECEPTOR B4;
FIBROBLAST GROWTH FACTOR;
GEFITINIB;
GFB 204;
IMIDAZOPYRIDINE DERIVATIVE;
KI 23057;
LY 2401401;
PACLITAXEL;
PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;
PROTEIN TYROSINE KINASE INHIBITOR;
RAPAMYCIN;
RECENTIN;
SEMAPHORIN;
SEMAPHORIN 5A;
SORAFENIB;
SUNITINIB;
THALIDOMIDE;
THROMBOSPONDIN 1;
UNCLASSIFIED DRUG;
VANDETANIB;
VASCULOTROPIN;
VASCULOTROPIN INHIBITOR;
VASCULOTROPIN RECEPTOR;
YH 16;
ANGIOGENESIS;
BREAST CANCER;
CANCER;
CANCER CHEMOTHERAPY;
CANCER INHIBITION;
COLON CARCINOMA;
COLORECTAL CANCER;
CONFERENCE PAPER;
DRUG MECHANISM;
GLIOBLASTOMA;
HUMAN;
INHIBITION KINETICS;
LUNG ADENOCARCINOMA;
LUNG CANCER;
LYMPHANGIOGENESIS;
MESOTHELIOMA;
NONHUMAN;
RECTUM CANCER;
TUMOR VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
HUMANS;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
RESEARCH;
|
|
EID: 34250618421
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (0)
|
